Ligand Pharmaceuticals | Pasivo Circulante

Current Liabilities Cambio Fecha
Amgen USD 18.39B 1.44B 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
Baxter International USD 6.5B 294M 2023-12
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Insmed USD 225.63M 28.9M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Ligand Pharmaceuticals USD 16.78M 1.06M 2023-12
Merck USD 23.09B 300M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Pfizer USD 31.14B 3.51B 2023-09
Veracyte USD 61.24M 3.98M 2023-12



Ligand Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.